The Long-Term Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Among Illicit Drug Users: A Modeling Study

被引:8
|
作者
Javanbakht, Mehdi [1 ,2 ]
Mirahmadizadeh, Alireza [3 ]
Mashayekhi, Atefeh [4 ]
机构
[1] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen, Scotland
[2] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz, Iran
[4] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Hlth Management & Econ Res Ctr, Tehran, Iran
关键词
Hepatitis C Virus; Iran; Methadone Maintenance Treatment; Quality Adjusted Life Years; Illicit Drug Users; Markov Model; HUMAN-IMMUNODEFICIENCY-VIRUS; COST-EFFECTIVENESS; SEXUAL TRANSMISSION; PROSPECTIVE COHORT; INJECT DRUGS; RISK-FACTORS; INFECTION; PREVALENCE; IMPACT; METAANALYSIS;
D O I
10.5812/ircmj.13484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic infection with hepatitis C virus (HCV) is increasingly recognized as a major global health problem. Illicit injection drug use is an important risk factor for the rising hepatitis C virus (HCV) prevalence in IR Iran. Objectives: The objective of this study was to determine the long-term effectiveness (total quality adjusted life years (QALYs) gained) of methadone maintenance treatment (MMT program) in prevention of HCV infection among injecting drug users (IDUs). Materials and Methods: A number of Markov models were developed to model morbidity and mortality among IDUs. The input data used in modeling were collected by a self-reported method from 259 IDUs before registration and one year after MMT and also from previous studies. One way and probabilistic sensitivity analyses were done to show the effects of uncertainty in parameters on number of life years and QALYs saved. The expected consequences were estimated using a life-time time horizon for the two strategies including implementation and not implementation of the MMT program. Results: Our model estimated that total number of discounted life years lived per IDU with and without the MMT program would be 5.15 (5.05- 5.25) and 4.63 (4.42- 4.81),respectively. The model also estimated that total number of discounted QALYs lived per IDU with and without the MMT program would be 4.11 (3.86-4.41) and 2.45 (2.17 - 2.84). Simulation results indicated that all differences in life years and QALYs lived between the two strategies were statistically significant (p < 0.001). Based on our model, total discounted life years and QALYs saved in a cohort of 1000 IDUs were 1790 (1520 - 2090) and 1590 (1090-2090), respectively. Conclusions: Considering the high prevalence of illicit injecting drug use in Iran and MMT effectiveness in prevention of HCV infection, it is necessary to develop MMT centers at regional and national levels.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995
    Broers, B
    Junet, C
    Bourquin, M
    Déglon, JJ
    Perrin, L
    Hirschel, E
    AIDS, 1998, 12 (15) : 2059 - 2066
  • [42] The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study
    Di Martino, V
    Rufat, P
    Boyer, N
    Renard, P
    Degos, F
    Martinot-Peignoux, M
    Matheron, S
    Le Moing, V
    Vachon, F
    Degott, C
    Valla, D
    Marcellin, P
    HEPATOLOGY, 2001, 34 (06) : 1193 - 1199
  • [43] Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
    Sroczynski, G.
    Esteban, E.
    Conrads-Frank, A.
    Schwarzer, R.
    Muehlberger, N.
    Wright, D.
    Zeuzem, S.
    Siebert, U.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 34 - 50
  • [44] Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance
    Willner-Reid, Jessica
    Belendiuk, Katherine A.
    Epstein, David H.
    Schmittner, John
    Preston, Kenzie L.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2008, 35 (01) : 78 - 86
  • [45] Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment
    Backmund, M
    Reimer, J
    Meyer, K
    Gerlach, JT
    Zachoval, R
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S330 - S335
  • [46] HEPATITIS C Enhancing treatment for hepatitis C among drug users
    Grebely, Jason
    Dore, Gregory J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (01) : 11 - 13
  • [47] NOTIFICATION OF HEPATITIS C SEROSTATUS IMPROVES THE ADHERENCE OF HCV SEROPOSITIVE DRUG USERS RECEIVING METHADONE MAINTENANCE TREATMENT
    Zhang, Huaihui
    Wang, Zhenhua
    Li, Yongchao
    Han, Hesong
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 45 : S308 - S308
  • [48] Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infection
    Sroczynski, Gaby
    Esteban, Eva
    Conrads-Frank, Annette
    Schwarzer, Ruth
    Muehlberger, Nikolai
    Wright, Davene
    Zeuzem, Stefan
    Siebert, Uwe
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (03): : 245 - 253
  • [49] A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users
    Wright N.M.J.
    Tompkins C.N.E.
    Harm Reduction Journal, 3 (1)
  • [50] Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study
    van Beek, I
    Dwyer, R
    Dore, GJ
    Luo, KH
    Kaldor, JM
    BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7156): : 433 - 437